No influence of antihypertensive agents on plasma free metanephrines

Clinical Biochemistry

Volumn 49, Issue 18, 2016, Pages 1368-1371

  Osinga, Thamara E ^a   Kema, Ido P ^a   Kerstens, Michiel N ^a   de Jong, Wilhelmina H A ^a   van Faassen, Martijn ^a   Dullaart, Robin P F ^a   Links, Thera P ^a   van der Horst Schrivers, Anouk N A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antihypertensive medication; Metanephrines; Pheochromocytoma; blockers

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHLORTALIDONE; ENALAPRIL; HYDROCHLOROTHIAZIDE; LABETALOL; LISINOPRIL; METADRENALIN; METOPROLOL; NORMETADRENALIN; PERINDOPRIL; PROPRANOLOL; RAMIPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; AGED; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; METANEPHRINE; MIDDLE AGED; TANDEM MASS SPECTROMETRY;

EID: 84999751698     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.06.004     Document Type: Article

References (31)

1. [1] Lenders, J.W.M., Keiser, H.R., Goldstein, D.S., Willemsen, J.J., Friberg, P., Jacobs, M.C., et al. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann. Intern. Med. 123 (1995), 101–109.
2. [2] Lenders, J.W.M., Duh, Q.Y., Eisenhofer, G., Gimenez-Roqueplo, A.P., Grebe, S.K., Murad, M.H., et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99 (2014), 1915–1942.
3. [3] Lenders, J.W.M., Pacak, K., Walther, M.M., Linehan, W.M., Mannelli, M., Friberg, P., et al. Biochemical diagnosis of pheochromocytoma: which test is best?. JAMA 287 (2002), 1427–1434.
4. [4] Lenders, J.W.M., Eisenhofer, G., Mannelli, M., Pacak, K., Phaeochromocytoma. Lancet 366 (2005), 665–675.
5. [5] Amar, L., Servais, A., Gimenez-Roqueplo, A.P., Zinzindohoue, F., Chatellier, G., Plouin, P.F., Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J. Clin. Endocrinol. Metab. 90 (2005), 2110–2116.
6. [6] Mannelli, M., Ianni, L., Cilotti, A., Conti, A., Pheochromocytoma in Italy: a multicentric retrospective study. Eur. J. Endocrinol. 141 (1999), 619–624.
7. [7] Pacak, K., Linehan, W.M., Eisenhofer, G., Walther, M.M., Goldstein, D.S., Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann. Intern. Med. 134 (2001), 315–329.
8. [8] Stein, P.P., Black, H.R., A simplified diagnostic approach to pheochromocytoma. A review of the literature 20 and report of one institution's experience. Medicine (Baltimore) 70 (1991), 46–66.
9. [9] Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. Jr., et al. National Heart, Lung, and Blood Institute joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003), 2560–2572.
10. [10] Lenders, J.W.M., Willemsen, J.J., Eisenhofer, G., Ross, H.A., Pacak, K., Timmers, H.J.L.M., et al. Is supine rest necessary before blood sampling for plasma metanephrines?. Clin. Chem. 53 (2007), 352–354.
11. [11] Eisenhofer, G., Lattke, P., Herberg, M., Siegert, G., Qin, N., Därr, R., et al. Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma. Ann. Clin. Biochem. 50 (2013), 62–69.
12. [12] Deutschbein, T., Unger, N., Jaeger, A., Broecker-Preuss, M., Mann, K., Petersenn, S., Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasma. Clin. Endocrinol. 73 (2010), 153–160.
13. [13] Robertson, D., Frolich, J.C., Carr, R.K., Watson, J.T., Hollifield, J.W., Shand, D.G., et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N. Engl. J. Med. 298 (1978), 181–186.
14. [14] Kerstens, M.N., Kema, I.P., Dullaart, R.P.F., Plasma normetanephrine concentrations are affected by dietary sodium intake. Clin. Chim. Acta 413 (2012), 1716–1717.
15. [15] de Jong, W.H.A., Eisenhofer, G., Muskiet, F.A.J., de Vries, E.G.E., Kema, I.P., Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors. J. Clin. Endocrinol. Metab. 94 (2009), 2841–2849.
16. [16] Osinga, T.E., van den Eijnden, M.H.A., Kema, I.P., Kerstens, M.N., Dullaart, R.P.F., de Jong, W.H.A., et al. Unilateral and bilateral adrenalectomy for pheochromocytoma requires adjustment of urinary and plasma metanephrine reference ranges. J. Clin. Endocrinol. Metab. 98 (2013), 1076–1083.
17. [17] Pamporaki, C., Bursztyn, M., Reimann, M., Ziemssen, T., Bornstein, S.R., Sweep, F.C., et al. Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma. Eur. J. Endocrinol. 170 (2014), 349–357.
18. [18] Eisenhofer, G., Goldstein, D.S., Walther, M.M., Friberg, P., Lenders, J.W.M., Keiser, H.R., et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J. Clin. Endocrinol. Metab. 88 (2003), 2656–2666.
19. [19] Bouhanick, B., Fauvel, J., Pont, F., Biochemical misdiagnosis of pheochromocytoma in patients treated with sulfasalazine. JAMA 304 (2010), 1898–1901.
20. [20] Lenders, J.W.M., Eisenhofer, G., Armando, I., Keiser, H.R., Goldstein, D.S., Kopin, I.J., Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin. Chem. 39 (1993), 97–103.
21. [21] Davidson, F.D., Paracetamol-associated interference in an HPLC-ECD assay for urinary free metadrenalines and catecholamines. Ann. Clin. Biochem. 41 (2004), 316–320.
22. [22] Ito, T., Imai, T., Kikumori, T., Shibata, A., Horiba, T., Kobayashi, H., et al. Adrenal incidentaloma: review of 197 patients and report of a drug-related false-positive urinary normetanephrine result. Surg. Today 36 (2006), 961–965.
23. [23] Peaston, R.T., Graham, K.S., Chambers, E., van der Molen, J.C., Ball, S., Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma. Clin. Chim. Acta 411 (2010), 546–552.
24. [24] Pillai, D., Callen, S., Pilot quality assurance programme for plasma metanephrines. Ann. Clin. Biochem. 47 (2010), 137–142.
25. [25] Neary, N.M., King, K.S., Pacak, K., Drugs and pheochromocytoma–don't be fooled by every elevated metanephrine. N. Engl. J. Med. 364 (2011), 2268–2270.
26. [26] Finberg, J.P., Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. Pharmacol. Ther. 143 (2014), 133–152.
27. [27] Yu, R., Wei, M., False positive test results for pheochromocytoma from 2000 to 2008. Exp. Clin. Endocrinol. Diabetes 118 (2010), 577–585.
28. [28] Harding, J.L., Yeh, M.W., Robinson, B.G., Delbridge, L.W., Sidhu, S.B., Potential pitfalls in the diagnosis of phaeochromocytoma. Med. J. Aust. 182 (2005), 637–640.
29. [29] James, P.A., Oparil, S., Carter, B.L., Cushman, W.C., Dennison-Himmelfarb, C., Handler, J., et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311 (2014), 507–520.
30. [30] de Jong, W.H.A., Graham, K.S., van der Molen, J.C., Links, T.P., Morris, M.R., Ross, H.A., et al. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. Clin. Chem. 53 (2007), 1684–1693.
31. [31] van Berkel, A., Lenders, J.W., Timmers, H.J., Diagnosis of endocrine disease: biochemical diagnosis of phaeochromocytoma and paraganglioma. Eur. J. Endocrinol. 170 (2014), R109–R119.